Health
Novavax coronavirus vaccine shown to be 89 per cent effective in UK trial – SBS News
A mid-stage trial of the vaccine in South Africa, where a new variant of the virus is common, showed 60 per cent effectiveness among people who did not have HIV….
Novavax Inc said on Thursday its vaccine was 89.3 per cent effective in preventing COVID-19 in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly contagious variant first discovered there, according to a preliminary analysis.
A mid-stage trial of the vaccine in South Africa, where a troubling new variant of the virus is common, showed 60 per cent effectiveness among people who did not have HIV.
Novavax shares surged 34 per cent in after hours…
-
Noosa News18 hours agoYoung voices shape Sunshine Coast’s future
-
Business18 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News17 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News15 hours agoCopperString transmission line projected to cost almost $14b amid massive blowout